CAMURUS AB CAMURUS ORD SHS - stock earnings
0RD1.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 86.4 million SEK | 384.0 million SEK |
| 2023Q2 | 301.4 million SEK | 674.3 million SEK |
| 2023Q1 | 58.8 million SEK | 284.0 million SEK |
| 2022Q4 | 13.1 million SEK | 268.0 million SEK |
| 2021Q3 | -6.2 million SEK | 154.0 million SEK |
| 2021Q2 | -48.4 million SEK | 137.9 million SEK |
| 2021Q1 | -21.9 million SEK | 125.9 million SEK |
| 2020Q4 | -65.5 million SEK | 105.6 million SEK |
| 2020Q3 | -20.3 million SEK | 100.3 million SEK |
0RD1.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 55.6 million SEK | 956.3 million SEK |
| 2021 | -90.4 million SEK | 600.6 million SEK |
| 2020 | -167.3 million SEK | 336.0 million SEK |
| 2019 | -289.9 million SEK | 105.6 million SEK |
| 2018 | -234.7 million SEK | 49.3 million SEK |
| 2017 | -190.6 million SEK | 54.3 million SEK |
| 2016 | -81.0 million SEK | 113.7 million SEK |
0RD1.L
Price: SEK560.50
52 week price:
Earnings Per Share: -1.27 SEK
P/E Ratio: -355.10
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 234.4 million